Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Miguel Ángel Mendoza-Torres"'
Autor:
Víctor Hugo García y García, Gerardo Santos-López, Laura Sánchez-Reza, Julio Reyes-Leyva, Juan Ernesto López-Ramos, Belinda Guzmán-Flores, Francisca Sosa-Jurado, Daniel Meléndez-Mena, Paulina Cortés-Hernández, Verónica Vallejo-Ruiz, Miguel Ángel Mendoza-Torres, Juan Carlos Balandrán, José Antonio Enciso-Moreno
Publikováno v:
European Cytokine Network. 32:23-30
Chronic hepatitis B (CHB) is classified into five phases based on virus-host interactions: immune tolerance, immune clearance, inactive carrier state, reactive phase and occult hepatitis B infection (OBI). OBI is an uncommon asymptomatic phase of CHB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a6f710b1e07828cf940045b3c565323
https://doi.org/10.1684/ecn.2021.0466
https://doi.org/10.1684/ecn.2021.0466
Autor:
Miguel Ángel Mendoza-Torres, Belinda Guzmán-Flores, Elain Rivera-García, María Del Carmen Baxin Domínguez, Francisca Sosa-Jurado, Paulina Cortés-Hernández, Julio Reyes-Leyva, José Manuel Coronel Espinoza, Verónica Vallejo-Ruiz, Daniel Meléndez-Mena, Iván Galindo-Santiago, Laura Sánchez-Reza, Virginia Sedeño-Monge, Gerardo Santos-López, Víctor Hugo García y García, Ygnacio Martínez-Laguna, Juan Carlos Flores-Alonso
Publikováno v:
PeerJ
PeerJ, Vol 9, p e12051 (2021)
PeerJ, Vol 9, p e12051 (2021)
Background Direct Acting Antivirals (DAAs) represent a large improvement in the treatment of chronic hepatitis C, resulting in Methods A descriptive, ambispective, longitudinal study was conducted. A cohort of 261 adult patients received PegIFNα2a+R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc70169d402d429fb722070344ef1e19
http://europepmc.org/articles/PMC8451435
http://europepmc.org/articles/PMC8451435
Autor:
Alejandra Elizabeth th Salazar-Marcelino, Javier er Toledo-Estrada, Teresita Romero-Ogawa, Miguel Ángel Mendoza-Torres, José Carlos os Herrera-García
Publikováno v:
NCT Neumología y Cirugía de Tórax. 75:18-24
El sindrome hepatopulmonar (SHP) es una de las manifestaciones extrahepaticas menos frecuentes de la insuficiencia hepatica. Tiene una incidencia de 13 a 47%, con una sobrevida de 40% a 2.5 anos. Objetivo: Describir el diagnostico y la evolucion clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d59e34dd400969afa447ae21ee50349
https://doi.org/10.35366/65156
https://doi.org/10.35366/65156
Autor:
Julio Reyes-Leyva, Paulina Cortés-Hernández, Verónica Vallejo-Ruiz, Roberto Barcenas-Villalobos, Gerardo Santos-López, Miguel Ángel Mendoza-Torres, Daniel Meléndez-Mena, Luis Márquez-Domínguez, Nora Hilda Rosas-Murrieta, Francisca Sosa-Jurado, Belinda Guzmán-Flores
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205356 (2018)
PLoS ONE
PLoS ONE
Background Occult hepatitis B infection (OBI) is defined as the presence of hepatitis B virus (HVB) DNA in the liver of HBsAg negative individuals with or without detectable viral DNA in serum. OBI is a diagnostic challenge as it is characterized by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6ad12cd6eaaaa9845a06977e5f4eb6f
http://europepmc.org/articles/PMC6179258?pdf=render
http://europepmc.org/articles/PMC6179258?pdf=render
Autor:
Verónica L Hernández-Galindo, Daniel Meléndez-Mena, Julio Reyes-Leyva, Verónica Vallejo-Ruiz, Fernando J Martínez-Arroniz, Miguel Ángel Mendoza-Torres, Gerardo Santos-López, Francisca Sosa-Jurado
Publikováno v:
BMC Infectious Diseases
Background Hepatitis C virus (HCV) is mainly transmitted by parenteral route, being blood transfusion and intravenous drug use the most frequent risk factors. However, it has been suggested that there are other routes of transmission. There are sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fbb8577ff68364436b0668073d857b4
https://doi.org/10.1186/1471-2334-14-72
https://doi.org/10.1186/1471-2334-14-72
Autor:
Daniel Melendez-Mena, Miguel Angel Mendoza-Torres, Virginia Sedeño-Monge, Víctor Hugo García y García, Elain Rivera-García, Laura Sánchez-Reza, María del Carmen Baxin Domínguez, Belinda Guzmán-Flores, Ygnacio Martinez-Laguna, José Manuel Coronel Espinoza, Iván Galindo-Santiago, Juan Carlos Flores-Alonso, Verónica Vallejo-Ruiz, Paulina Cortes-Hernandez, Julio Reyes-Leyva, Francisca Sosa-Jurado, Gerardo Santos-López
Publikováno v:
PeerJ, Vol 9, p e12051 (2021)
Background Direct Acting Antivirals (DAAs) represent a large improvement in the treatment of chronic hepatitis C, resulting in
Externí odkaz:
https://doaj.org/article/6e46c72cda824a66a13c9987ba46624e